State Street Corp Collegium Pharmaceutical, Inc Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, State Street Corp holds 1,373,326 shares of COLL stock, worth $41.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,373,326

Previous 1,379,953 0.48%

Holding current value

$41.2 Million

Previous $44.4 Million 19.42%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$31.4 - $39.07 $208,087 - $258,916	-6,627 Reduced 0.48%	1,373,326 $53.1 Million
Q2 2024 Aug 14, 2024	BUY	$31.36 - $39.99 $1.91 Million - $2.44 Million	60,898 Added 4.62%	1,379,953 $44.4 Million
Q1 2024 May 15, 2024	BUY	$31.23 - $40.91 $161,771 - $211,913	5,180 Added 0.39%	1,319,055 $51.2 Million
Q4 2023 Feb 14, 2024	BUY	$21.16 - $30.8 $494,699 - $720,073	23,379 Added 1.81%	1,313,875 $40.4 Million
Q3 2023 Nov 14, 2023	BUY	$21.23 - $24.28 $488,863 - $559,095	23,027 Added 1.82%	1,290,496 $28.8 Million
Q2 2023 Aug 14, 2023	SELL	$21.06 - $24.0 $1.79 Million - $2.05 Million	-85,223 Reduced 6.3%	1,267,469 $27.2 Million
Q1 2023 May 15, 2023	BUY	$23.0 - $29.88 $1.48 Million - $1.93 Million	64,478 Added 5.01%	1,352,692 $32.5 Million
Q4 2022 Feb 14, 2023	SELL	$16.14 - $23.55 $1.2 Million - $1.75 Million	-74,448 Reduced 5.46%	1,288,214 $29.9 Million
Q3 2022 Nov 15, 2022	SELL	$15.46 - $20.1 $433,359 - $563,423	-28,031 Reduced 2.02%	1,362,662 $21.8 Million
Q2 2022 Aug 15, 2022	BUY	$14.22 - $20.88 $1.17 Million - $1.72 Million	82,526 Added 6.31%	1,390,693 $24.6 Million
Q1 2022 May 16, 2022	BUY	$17.2 - $22.5 $2.84 Million - $3.72 Million	165,144 Added 14.45%	1,308,167 $26.6 Million
Q4 2021 Feb 14, 2022	SELL	$17.5 - $21.35 $151,182 - $184,442	-8,639 Reduced 0.75%	1,143,023 $21.4 Million
Q3 2021 Nov 15, 2021	SELL	$17.75 - $25.39 $49,007 - $70,101	-2,761 Reduced 0.24%	1,151,662 $22.7 Million
Q2 2021 Aug 16, 2021	BUY	$21.74 - $25.28 $1.27 Million - $1.47 Million	58,221 Added 5.31%	1,154,423 $27.3 Million
Q1 2021 May 17, 2021	BUY	$19.25 - $26.1 $6.41 Million - $8.68 Million	332,734 Added 43.58%	1,096,202 $26 Million
Q4 2020 Feb 16, 2021	BUY	$17.83 - $22.29 $194,471 - $243,117	10,907 Added 1.45%	763,468 $15.3 Million
Q3 2020 Nov 10, 2020	SELL	$15.78 - $20.82 $987,543 - $1.3 Million	-62,582 Reduced 7.68%	752,561 $15.7 Million
Q2 2020 Aug 14, 2020	BUY	$15.49 - $23.51 $1.63 Million - $2.48 Million	105,337 Added 14.84%	815,143 $14.3 Million
Q1 2020 May 11, 2020	BUY	$13.89 - $25.45 $9.86 Million - $18.1 Million	709,806 New	709,806 $11.6 Million

Others Institutions Holding COLL

# of Institutions

255

Shares Held

38.6M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.02B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Collegium Pharmaceutical, Inc Transaction History